Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor de Ledinghen

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|January 20, 2022
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complicationsAurélie Plessier, Marina Esposito-Farèse, Anna Baiges, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2021
Large-scale screening of lipase acid deficiency in at risk populationAbdellah Tebani, Bénédicte Sudrié-Arnaud, Hela Boudabous, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Gastroenterology|April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosisChristophe Hézode, Helene Fontaine, Celine Dorival, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2018
The epidemiology of Budd-Chiari syndrome in FranceIsabelle Ollivier-Hourmand, Manon Allaire, Nathalie Goutte, et al.
Gut|January 22, 2021
Two-dimensional shear wave elastography predicts survival in advanced chronic liver diseaseJonel Trebicka, Wenyi Gu, Victor de Ledinghen, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|January 20, 2022
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complicationsAurélie Plessier, Marina Esposito-Farèse, Anna Baiges, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2021
Large-scale screening of lipase acid deficiency in at risk populationAbdellah Tebani, Bénédicte Sudrié-Arnaud, Hela Boudabous, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Gastroenterology|April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosisChristophe Hézode, Helene Fontaine, Celine Dorival, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2018
The epidemiology of Budd-Chiari syndrome in FranceIsabelle Ollivier-Hourmand, Manon Allaire, Nathalie Goutte, et al.
Gut|January 22, 2021
Two-dimensional shear wave elastography predicts survival in advanced chronic liver diseaseJonel Trebicka, Wenyi Gu, Victor de Ledinghen, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 18